[Double-blind study using flufenamic acid (F.I. 440) and oxyphenylbutazone in rheumatoid arthritis and ankylosing spine].
D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005439:Flufenamic Acid / Q000494:pharmacology; D005461:Fluorine / Q000494:pharmacology; D006801:Humans; D010113:Oxyphenbutazone / Q000494:pharmacology*; D012600:Scoliosis / Q000188:drug therapy*; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D005461:Fluorine; D005439:Flufenamic Acid; D010113:Oxyphenbutazone
Experiencia doble ciego con ácido flufenámico (F.I. 440) y oxifenil-butazona en la artritis reumatoide y la espina anquilosante.